Type 1 narcolepsy is caused by a loss of hypocretin (orexin) signaling in the brain. Genetic data suggests the disorder is caused by an autoimmune attack on hypocretin producing neurons in hypothalamus. This hypothesis has however not yet been confirmed by consistent findings of autoreactive antibodies or T-cells in patient samples. One explanation for these negative results may be that the autoimmune process is no longer active when patients present to the clinic. With increasing awareness in recent years, more and more patients have been diagnosed closer and closer to disease onset. In this study, we tested whether an active immune process in the brain could be detected in these patients, as reflected by increased cytokine levels in the cerebrospinal fluid (CSF). Using multiplex analysis, we measured the levels of 51 cytokines and chemokines in the CSF of 40 type 1 narcolepsy patients having varying disease duration. For comparison, we used samples from 9 healthy controls and 9 patients with other central hypersomnia. Cytokine levels did not differ significantly between controls and patients, even in 5 patients with disease onset less than a month prior to CSF sampling.

Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset / Kornum, B. R.; Pizza, F.; Knudsen, S.; Plazzi, G.; Jennum, P.; Mignot, E.. - In: BRAIN BEHAVIOR AND IMMUNITY. - ISSN 0889-1591. - 49:(2015), pp. 54-58. [10.1016/j.bbi.2015.03.004]

Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset

G. Plazzi;
2015

Abstract

Type 1 narcolepsy is caused by a loss of hypocretin (orexin) signaling in the brain. Genetic data suggests the disorder is caused by an autoimmune attack on hypocretin producing neurons in hypothalamus. This hypothesis has however not yet been confirmed by consistent findings of autoreactive antibodies or T-cells in patient samples. One explanation for these negative results may be that the autoimmune process is no longer active when patients present to the clinic. With increasing awareness in recent years, more and more patients have been diagnosed closer and closer to disease onset. In this study, we tested whether an active immune process in the brain could be detected in these patients, as reflected by increased cytokine levels in the cerebrospinal fluid (CSF). Using multiplex analysis, we measured the levels of 51 cytokines and chemokines in the CSF of 40 type 1 narcolepsy patients having varying disease duration. For comparison, we used samples from 9 healthy controls and 9 patients with other central hypersomnia. Cytokine levels did not differ significantly between controls and patients, even in 5 patients with disease onset less than a month prior to CSF sampling.
2015
11-mar-2015
49
54
58
Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset / Kornum, B. R.; Pizza, F.; Knudsen, S.; Plazzi, G.; Jennum, P.; Mignot, E.. - In: BRAIN BEHAVIOR AND IMMUNITY. - ISSN 0889-1591. - 49:(2015), pp. 54-58. [10.1016/j.bbi.2015.03.004]
Kornum, B. R.; Pizza, F.; Knudsen, S.; Plazzi, G.; Jennum, P.; Mignot, E.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0889159115000756-main.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 408.58 kB
Formato Adobe PDF
408.58 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1205851
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 27
social impact